# A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients

> **NCT06672692** · NA · RECRUITING · sponsor: **DiaSorin Molecular LLC** · enrollment: 1000 (estimated)

## Conditions studied

- Influenza a
- Influenza B
- RSV
- COVID 19

## Interventions

- **DIAGNOSTIC_TEST:** LIAISON NES FLU A/B, RSV & COVID-19

## Key facts

- **NCT ID:** NCT06672692
- **Lead sponsor:** DiaSorin Molecular LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-30
- **Primary completion:** 2025-03
- **Final completion:** 2025-05
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06672692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06672692, "A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT06672692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*